NYSE: MDTMedtronic plc Stock Forecast, Predictions & Price Target
Analyst price target for MDT
Based on 20 analysts offering 12 month price targets for Medtronic plc.
Min Forecast
$92.00-15.19%
Avg Forecast
$119.05+9.74%
Max Forecast
$138.00+27.21%
Should I buy or sell MDT stock?
Strong Buy
Strong Buy
15 analysts 71.43%
Buy
3 analysts 14.29%
Hold
3 analysts 14.29%
Sell
0 analysts 0.00%
Strong Sell
0 analysts 0.00%
Forecast return on equity
Is MDT forecast to generate an efficient return?
Company
16.42%
Industry
31.71%
Market
-1.26%
MDT's Return on Equity is forecast to be low in 3 years (16.42%); analysts are not confident in the firm's ability to efficiently generate return on equity
Forecast
Forecast return on assets
Is MDT forecast to generate an efficient return on assets?
Company
8.79%
Industry
13.88%
Market
11.45%
MDT is forecast to generate lower Return on Assets (8.79%) than the US Medical Devices industry average (13.88%)
Forecast
MDT earnings per share forecast
What is MDT's earnings per share in the next 3 years based on estimates from 14 analysts?
Avg 1 year Forecast
$3.93+19.58%
Avg 2 year Forecast
$5.35+62.75%
Avg 3 year Forecast
$6.16+87.11%
MDT's earnings are forecast to grow at an exceptional rate of 24.64% per year
Forecast
MDT revenue forecast
What is MDT's revenue in the next 3 years based on estimates from 11 analysts?
Avg 1 year Forecast
$29.1B+4.31%
Avg 2 year Forecast
$32.0B+14.67%
Avg 3 year Forecast
$33.6B+20.17%
MDT's revenue is forecast to grow at a rate of 6.73% per year, which is not exceptional
Forecast
MDT earnings growth forecast
How is MDT forecast to perform vs Medical Devices companies and vs the US market?
Company
24.64%
Industry
34.55%
Market
14.77%
MDT's earnings are forecast to grow slower (24.64% per year) than the US Medical Devices industry average (34.55%)
Forecast
MDT's earnings are forecast to grow faster (24.64% per year) than the US market average (14.77%)
Forecast
MDT revenue growth forecast
How is MDT forecast to perform vs Medical Devices companies and vs the US market?
Company
6.73%
Industry
8.69%
Market
5.69%
MDT's revenues are forecast to grow slower (6.73% per year) than the US Medical Devices industry average (8.69%)
Forecast
MDT's revenues are forecast to grow faster (6.73% per year) than the US market average (5.69%)
Forecast
Medtronic Stock Forecast FAQ
Is Medtronic Stock a good buy in 2020, according to Wall Street analysts?
The consensus among 21 Wall Street analysts covering (NYSE: MDT) stock is to Strong Buy MDT stock.
Out of 21 analysts, 15 (71.43%) are recommending MDT as a Strong Buy, 3 (14.29%) are recommending MDT as a Buy, 3 (14.29%) are recommending MDT as a Hold, 0 (0.00%) are recommending MDT as a Sell, and 0 (0.00%) are recommending MDT as a Strong Sell.
What is MDT's Price Target?
According to 20 Wall Street analysts that have issued a 1 year MDT price target, the average MDT price target is $119.05, with the highest MDT stock price forecast at $138.00 and the lowest MDT stock price forecast at $92.00.
On average, Wall Street analysts predict that Medtronic's share price could reach $119.05 by Oct 15, 2021. The average Medtronic stock price prediction forecasts a potential upside of 9.74% from the current MDT share price of $108.48.
What is MDT's earnings growth forecast for 2021-2023?
(NYSE: MDT) Medtronic's forecast annual earnings growth rate of 24.64% is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 34.55%, and while it is forecast to beat the US market's average forecast earnings growth rate of 14.77%.
Medtronic's earnings in 2020 is $4,412,000,000.On average, 14 Wall Street analysts forecast MDT's earnings for 2021 to be $5,277,072,191, with the lowest MDT earnings forecast at $5,029,870,808, and the highest MDT earnings forecast at $5,405,434,494. On average, 13 Wall Street analysts forecast MDT's earnings for 2022 to be $7,182,118,994, with the lowest MDT earnings forecast at $2,105,839,245, and the highest MDT earnings forecast at $8,141,684,214.
In 2023, MDT is forecast to generate $8,257,035,918 in earnings, with the lowest earnings forecast at $7,779,533,516 and the highest earnings forecast at $8,879,398,599.
What is MDT's revenue growth forecast for 2021-2023?
(NYSE: MDT) Medtronic's forecast annual revenue growth rate of 6.73% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.69%, and while it is forecast to beat the US market's average forecast revenue growth rate of 5.69%.
Medtronic's revenue in 2020 is $27,927,000,000.On average, 11 Wall Street analysts forecast MDT's revenue for 2021 to be $39,073,569,537,282, with the lowest MDT revenue forecast at $38,688,424,952,408, and the highest MDT revenue forecast at $39,764,455,154,515. On average, 10 Wall Street analysts forecast MDT's revenue for 2022 to be $42,953,196,075,534, with the lowest MDT revenue forecast at $41,657,711,939,447, and the highest MDT revenue forecast at $45,302,490,456,449.
In 2023, MDT is forecast to generate $45,012,270,934,753 in revenue, with the lowest revenue forecast at $42,397,116,361,138 and the highest revenue forecast at $47,971,849,600,484.
What is MDT's Earnings Per Share (EPS) forecast for 2021-2023?
(NYSE: MDT) Medtronic's current Earnings Per Share (EPS) is $3.29. On average, analysts forecast that MDT's EPS will be $3.93 for 2021, with the lowest EPS forecast at $3.75, and the highest EPS forecast at $4.03. On average, analysts forecast that MDT's EPS will be $5.35 for 2022, with the lowest EPS forecast at $1.57, and the highest EPS forecast at $6.07. In 2023, MDT's EPS is forecast to hit $6.16 (min: $5.80, max: $6.62).
What is MDT's forecast return on equity (ROE) for 2021-2023?
(NYSE: MDT) forecast ROE is 16.42%, which is considered weak.
What is MDT's forecast return on assets (ROA) for 2021-2023?
(NYSE: MDT) forecast ROA is 8.79%, which is lower than the forecast US Medical Devices industry average of 13.88%.
©2020 WallStreetZen
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
